The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov , Jaegil Kim , Nicholas J. Haradhvala +97 more 2020 Nature 3401 citations
Pan-cancer analysis of whole genomes Lauri A. Aaltonen , Federico Abascal , Adam Abeshouse +97 more 2020 Nature 3027 citations
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial Andrew X. Zhu , Yoon‐Koo Kang , Chia‐Jui Yen +21 more 2019 The Lancet Oncology 1593 citations